Morgan Rouprêt
University of Paris
CancerInternal medicineUrologySurgeryPathologyOncologyRetrospective cohort studyStage (cooking)CystectomyProstateCarcinomaProstatectomyProstate cancerNephrectomyBladder cancerGynecologyUrothelial carcinomaNephrologyMedicine
Publications 920
OBJECTIVE Annual countrywide data are scarce when comparing surgical approaches in terms of hospital stay outcomes and costs for radical prostatectomy (RP). We aimed to assess the impact of surgical approach on post-operative outcomes and costs after RP by comparing open (ORP), laparoscopic (LRP), and robot-assisted (RARP) RP in the French healthcare system. PATIENTS AND METHODS Data from all patients undergoing RP in France in 2020 were extracted from the central database of the national health...
#1Ekaterina Laukhtina (Medical University of Vienna)H-Index: 8
#2Sung Ryul Shim (KU: Korea University)H-Index: 1
Last. Benjamin Pradere (Medical University of Vienna)H-Index: 16
view all 22 authors...
Abstract null null Context null During the past decade, several urinary biomarker tests (UBTs) for bladder cancer have been developed and made commercially available. However, none of these is recommended by international guidelines so far. null null null Objective null To assess the diagnostic estimates of novel commercially available UBTs for diagnosis and surveillance of non–muscle-invasive bladder cancer (NMIBC) using diagnostic test accuracy (DTA) and network meta-analysis (NMA). null null ...
#1Mathieu RoumiguiéH-Index: 20
#2Eva Compérat (University of Paris)H-Index: 25
Last. Morgan Rouprêt (University of Paris)H-Index: 72
view all 17 authors...
PURPOSE To assess the association between PD-L1 expression and disease-free survival (DFS) in High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) patients treated with intravesical Bacillus Calmette-Guerin (BCG) instillations (IBI). METHODS Retrospective study in five French centres between 2001 and 2015. Participants were 140 patients with histologically confirmed HR-NMIBC. All patients received induction and maintenance IBI. Pathological stage/grade, concomitant carcinoma in situ, lesion n...
#4Eric BarretH-Index: 37
Abstract null null The evolution in the past decade of recommendations for prostate cancer (PCa) management, from screening to surgical treatment, may have affected the radical prostatectomy (RP) landscape. However, comprehensive data at a national level remain scarce. We extracted 5-yr data for RP patients in France from the central database of the national health care system. The primary endpoints were surgical approach (open [ORP], laparoscopic [LRP], and robot-assisted RP [RARP]), length of ...
#4Peter Wiklund (KI: Karolinska Institutet)H-Index: 55
#5Jihad H. Kaouk (Cleveland Clinic)H-Index: 99
Last. Prokar Dasgupta (Guy's Hospital)H-Index: 78
view all 24 authors...
#7Gilles Crehange (Curie Institute)H-Index: 11
#8Raphaële Renard-Penna (University of Paris)H-Index: 9
Last. Charles Dariane (University of Paris)H-Index: 5
view all 15 authors...
Background: Prostate-specific membrane antigen (PSMA) is not sufficiently overexpressed in a small proportion of prostate cancer (PCa) patients, who require other strategies for imaging and/or treatment. We reviewed potential targets other than PSMA for PCa theranostics in nuclear medicine that have already been tested in humans. Methods: We performed a systematic web search in the PubMed and Cochrane databases, with no time restrictions by pooling terms (“prostate cancer”, “prostatic neoplasms”...
#1Keiichiro Mori (Jikei University School of Medicine)H-Index: 10
#2Satoshi Katayama (Medical University of Vienna)H-Index: 3
Last. Shahrokh F. Shariat (UTSW: University of Texas Southwestern Medical Center)H-Index: 136
view all 19 authors...
Introduction null This study aimed to evaluate the concordance in tumor stage and grade between ureteroscopic (URS) biopsy and radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC). null Patients and methods null Records of 1,214 UTUC patients who had undergone URS biopsy followed by RNU were included. Univariable and multivariable logistic regression analyses were performed to identify factors contributing to the pathological upstaging. null Results null The ...
#1Maria Carmen MirH-Index: 20
#2Laurence Albiges (Université Paris-Saclay)H-Index: 61
Last. Morgan Rouprêt (University of Paris)H-Index: 72
view all 7 authors...
Abstract This case presents a 68-yr-old female patient with primary metastatic nonclear renal cell carcinoma (RCC) with multiple bone lesions. The patient underwent a single resection of skull bone lesion (diagnostic for poorly differentiated carcinoma of unknown origin) and cytoreductive nephrectomy. The pathology of the kidney specimen demonstrated an oncocytic papillary RCC. Within 3 mo, she developed skeletal progressive disease and was started on systemic therapy (sunitinib). After initial ...
#1Louis Lenfant (University of Paris)H-Index: 6
#2Alberto Breda (Autonomous University of Barcelona)H-Index: 30
Last. Morgan Rouprêt (University of Paris)H-Index: 72
view all 6 authors...
Abstract null null This case-based discussion describes the management of a 66-yr-old man who presented to the emergency department with gross hematuria. His urine cytology was benign, and computed tomography (CT) with nephrographic phase revealed a 2.5 cm filling defect within the left renal pelvis and luminal narrowing in the right proximal ureter with hydronephrosis. CT showed no lymphadenopathy and no sign of metastatic disease. Cystoscopy was normal. In a progressive case-based discussion f...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.